BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 24338115)

  • 1. The impact of noninvasive prenatal testing on the practice of maternal-fetal medicine.
    Friel LA; Czerwinski JL; Singletary CN
    Am J Perinatol; 2014 Oct; 31(9):759-64. PubMed ID: 24338115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uptake of noninvasive prenatal testing at a large academic referral center.
    Larion S; Warsof SL; Romary L; Mlynarczyk M; Peleg D; Abuhamad AZ
    Am J Obstet Gynecol; 2014 Dec; 211(6):651.e1-7. PubMed ID: 24954652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of fetal copy number variants by non-invasive prenatal testing for common aneuploidies.
    Li R; Wan J; Zhang Y; Fu F; Ou Y; Jing X; Li J; Li D; Liao C
    Ultrasound Obstet Gynecol; 2016 Jan; 47(1):53-7. PubMed ID: 26033469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Women's views and the impact of noninvasive prenatal testing on procedures in a managed care setting.
    Tiller GE; Kershberg HB; Goff J; Coffeen C; Liao W; Sehnert AJ
    Prenat Diagn; 2015 May; 35(5):428-33. PubMed ID: 25201151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Noninvasive prenatal testing: impact on genetic counseling, invasive prenatal diagnosis, and trisomy 21 detection.
    Wax JR; Cartin A; Chard R; Lucas FL; Pinette MG
    J Clin Ultrasound; 2015 Jan; 43(1):1-6. PubMed ID: 25303161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uptake of noninvasive prenatal testing (NIPT) in women following positive aneuploidy screening.
    Chetty S; Garabedian MJ; Norton ME
    Prenat Diagn; 2013 Jun; 33(6):542-6. PubMed ID: 23592525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trends in prenatal screening and diagnostic testing among women referred for advanced maternal age.
    Nakata N; Wang Y; Bhatt S
    Prenat Diagn; 2010 Mar; 30(3):198-206. PubMed ID: 20063323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential diagnostic consequences of applying non-invasive prenatal testing: population-based study from a country with existing first-trimester screening.
    Petersen OB; Vogel I; Ekelund C; Hyett J; Tabor A; ;
    Ultrasound Obstet Gynecol; 2014 Mar; 43(3):265-71. PubMed ID: 24375770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new era in prenatal care: non-invasive prenatal testing in Switzerland.
    Manegold-Brauer G; Kang Bellin A; Hahn S; De Geyter C; Buechel J; Hoesli I; Lapaire O
    Swiss Med Wkly; 2014 Feb; 144():w13915. PubMed ID: 24549748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abnormal non-invasive prenatal test results concordant with karyotype of cytotrophoblast but not reflecting abnormal fetal karyotype.
    Srebniak MI; Diderich KE; Noomen P; Dijkman A; de Vries FA; van Opstal D
    Ultrasound Obstet Gynecol; 2014 Jul; 44(1):109-11. PubMed ID: 24585494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of noninvasive prenatal testing as a diagnostic versus a screening tool--a cost-effectiveness analysis.
    Ohno M; Caughey A
    Prenat Diagn; 2013 Jul; 33(7):630-5. PubMed ID: 23674316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of noninvasive prenatal testing in regionally dispersed medical centers in the United States.
    Platt LD; Janicki MB; Prosen T; Goldberg JD; Adashek J; Figueroa R; Rodis J; Liao W; Sehnert AJ; Snyder HL; Warsof SL
    Am J Obstet Gynecol; 2014 Oct; 211(4):368.e1-7. PubMed ID: 24705127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The consequences of implementing non-invasive prenatal testing in Dutch national health care: a cost-effectiveness analysis.
    Beulen L; Grutters JP; Faas BH; Feenstra I; van Vugt JM; Bekker MN
    Eur J Obstet Gynecol Reprod Biol; 2014 Nov; 182():53-61. PubMed ID: 25238658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of first-trimester screening on AMA patients' uptake of invasive testing.
    Wray AM; Ghidini A; Alvis C; Hodor J; Landy HJ; Poggi SH
    Prenat Diagn; 2005 May; 25(5):350-3. PubMed ID: 15906421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical application of noninvasive prenatal diagnosis using cell free fetal DNA in maternal plasma].
    Hou QF; Wu D; Chu Y; Kang B; Liao SX; Yang YL; Zhang CY; Zhang JX; Wu G
    Zhonghua Fu Chan Ke Za Zhi; 2012 Nov; 47(11):813-7. PubMed ID: 23302120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fetal aneuploidy screening with cell-free DNA in late gestation.
    Taneja PA; Prosen TL; de Feo E; Kruglyak KM; Halks-Miller M; Curnow KJ; Bhatt S
    J Matern Fetal Neonatal Med; 2017 Feb; 30(3):338-342. PubMed ID: 27124739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical implementation of non-invasive prenatal study for detecting aneuploidies by fetal DNA based on single nucleotide polymorphisms: two years in Mexico].
    Sánchez-Usabiaga RA; Aguinaga-Ríos M; Batista-Espinoza A; Hurtado-Amador R; Romero-Tovar S
    Ginecol Obstet Mex; 2015 Apr; 83(4):220-31. PubMed ID: 26727755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. First-trimester screening and its impact on uptake of diagnostic testing.
    Darnes DR; Hashmi S; Monga M; Sullivan C; Vidaeff A; Berens P; Czerwinski JL
    Prenat Diagn; 2011 Sep; 31(9):892-6. PubMed ID: 21692093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utilization of noninvasive prenatal testing: impact on referrals for diagnostic testing.
    Williams J; Rad S; Beauchamp S; Ratousi D; Subramaniam V; Farivar S; Pisarska MD
    Am J Obstet Gynecol; 2015 Jul; 213(1):102.e1-102.e6. PubMed ID: 25882918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Noninvasive prenatal detection of aneuploidy.
    Robinson C; van den Boom D; Bombard AT
    Clin Obstet Gynecol; 2014 Mar; 57(1):210-25. PubMed ID: 24351443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.